What is the Return on Assets (ROA) of Genexine this year?
The Return on Assets (ROA) of Genexine is 0 undefined this year.
Genexine ROA 2024
Genexine ROA
0
Ticker
095700.KQ
ISIN
KR7095700001
In 2024, Genexine's return on assets (ROA) was 0, a -100% increase from the -0.14 ROA in the previous year.
Genexine Aktienanalyse
What does Genexine do?
Genexine Inc is a leading biotechnology company focused on developing therapies for serious diseases. The company was founded in Korea in 1999 and has since undergone impressive development. Genexine ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Genexine's Return on Assets (ROA)
Genexine's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Genexine's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Genexine's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Genexine’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Genexine stock
What was the ROA of Genexine compared to the previous year?
The ROA of Genexine has increased by -100% compared to the previous year.
What consequences do high ROA have for investors of Genexine?
A high ROA is advantageous for investors of Genexine, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Genexine?
A low ROA can be unfavorable for investors of Genexine as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Genexine affect the company?
An increase in ROA of Genexine can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Genexine impact the company?
A reduction in the ROA of Genexine can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Genexine?
Some factors that can influence the ROA of Genexine include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Genexine important for investors?
The ROA of Genexine is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Genexine take to improve ROA?
To improve ROA, Genexine can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Genexine pay?
Over the past 12 months, Genexine paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genexine is expected to pay a dividend of 0 KRW.
What is the dividend yield of Genexine?
The current dividend yield of Genexine is .
When does Genexine pay dividends?
Genexine pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genexine?
Genexine paid dividends every year for the past 0 years.
What is the dividend of Genexine?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genexine located?
Genexine is assigned to the 'Health' sector.
Wann musste ich die Aktien von Genexine kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genexine from 10/8/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 10/8/2024.
When did Genexine pay the last dividend?
The last dividend was paid out on 10/8/2024.
What was the dividend of Genexine in the year 2023?
In the year 2023, Genexine distributed 0 KRW as dividends.
In which currency does Genexine pay out the dividend?
The dividends of Genexine are distributed in KRW.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Genexine
Our stock analysis for Genexine Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genexine Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
